CASTLEARK MANAGEMENT LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
CASTLEARK MANAGEMENT LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,880,050
-58.3%
127,750
-37.9%
0.25%
-59.2%
Q4 2022$11,703,192
+36.6%
205,680
-5.1%
0.61%
+28.1%
Q3 2022$8,570,000
-4.5%
216,750
+6.3%
0.48%
-0.6%
Q2 2022$8,973,000
+0.4%
203,940
-7.2%
0.48%
+40.4%
Q3 2021$8,941,000
-38.0%
219,787
-30.8%
0.34%
-29.5%
Q2 2021$14,431,000
-19.6%
317,787
-26.2%
0.48%
-24.9%
Q1 2021$17,952,000
-15.8%
430,602
-13.7%
0.65%
-19.0%
Q4 2020$21,318,000
+35.5%
499,142
-16.6%
0.80%
+29.5%
Q3 2020$15,732,000
+4.6%
598,617
+6.7%
0.62%
-5.8%
Q2 2020$15,045,000
+91.0%
561,185
+28.2%
0.65%
+40.3%
Q1 2020$7,877,000
+10.3%
437,870
+3.4%
0.47%
+111.8%
Q2 2018$7,141,000
-15.8%
423,305
-2.2%
0.22%
-18.2%
Q1 2018$8,480,000
+19.5%
432,884
+23.6%
0.27%
+26.3%
Q4 2017$7,098,000
+75.4%
350,355
+50.4%
0.21%
+67.7%
Q3 2017$4,046,000232,9050.13%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders